Natural antibiofilm agents and the need for antibiofilm drug leads

Adnan Hazniza, Seidel Veronique, Tucker Nicholas P,

Full Text

Plant with medicinal property contains different types of bioactive compounds and these compounds are effective against certain diseases. Biofilm infection is a disease caused by biofilm which is associated with the respiratory and gastrointestinal infections. Biofilm-producing bacteria as such Pseudomonas aeruginosa strain PA14 is a serious treat in hospitals. The bacterium possesses many virulent factors that contributed to its pathogenesis and resistance thus caused the inhibition and removal of its biofilms a difficult task. This study therefore attempts to identify natural antibiofilm agents against the P. aeruginosa PA14 biofilms. The activity of plant extracts and subsequently purified compounds was evaluated using a stepwise separation process called bioassay-guided fractionation. The fractionation process involved the use of chromatographic techniques and compounds were identified using NMR, GC-MS and LC-MS. A total of four bioactive fractions namely (E333F1S1), (E341), (HA6) and (M338B) have been discovered with antibiofilm activity and were selected for further investigation. The active fraction from Ribes nigrum leaf (E333F1S1) contained mixtures of alkanes while active extract of Sambucus nigra flower (E341) contained a mixture of ursolic acid and oleanolic acid. The LC-MS analysis on Coriandrum sativum seeds (HA6) revealed the presence mixture of oxygenated monoterpenes, while another active fraction of C. sativum seeds (M338B) showed the presence of carboxylic acid, carboxylate, tetraone, glycerol, carbohydrate and fatty acids. Thus, the discovery of potential bioactive compounds from this study could be further investigated as antibiofilm drug leads to battle the infections by P. aeruginosa PA14 biofilm in the near future.

References

1. Suzutani, T., Ogasawara, M., Yoshida, I., Azuma, M. and Knox, Y. M. (2003). Anti-herpesvirus activity of an extract of Ribes nigrum L. Phytotherapy Research, 17, 609-13. 2. Budzynska, A., Wieckowska-Szakiel, M., Sadowska, B., Kalemba, D. and Rozalska, B. (2011). Antibiofilm activity of selected plant essential oils and their major components. Polish Journal of Microbiology, 60, 35-41. 3. Beutler, J. A. (2009). Natural products as a foundation for drug discovery. Current Protocols in Pharmacology, 46, 9 11 1. 4. Church, D., Elsayed, S., Reid, O., Winston, B. and Lindsay, R. (2006). Burn wound infections. Clinical Microbiology Reviews, 19, 403-34. 5. Lang, G. and Buchbauer, G. (2012). A review on recent research results (2008–2010) on essential oils as antimicrobials and antifungals. A review Flavour and Fragrance Journal, 27, 13-39. 6. Suzutani, T., Ogasawara, M., Yoshida, I., Azuma, M. and Knox, Y. M. (2003). Anti-herpesvirus activity of an extract of Ribes nigrum L. Phytotherapy Research, 17, 609-13. 7. Quave, C. L., Estevez-Carmona, M., Compadre, C. M., Hobby, G., Hendrickson, H., Beenken, K. E. and Smeltzer, M. S. (2012). Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One, 7, e28737. 8. Jiang, X., Yu, P., Jiang, J., Zhang, Z., Wang, Z., Yang, Z., Tian, Z., Wright, S. C., Larrick, J. W. and Wang, Y. (2009). Synthesis and evaluation of antibacterial activities of andrographolide analogues. European Journal of Medicinal Chemistry, 44, 2936-43. 9. Lee, D. G., Urbach, J. M., Wu, G., Liberati, N. T., Feinbaum, R. L., Miyata, S., Diggins, L. T., He, J., Saucier, M., Deziel, E., Friedman, L., Li, L., Grills, G., Montgomery, K., Kucherlapati, R., Rahme, L. G. and Ausubel, F. M. (2006). Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biology, 7, R90. 10. Adnan, H. (2015). Studies on the activity of selected plants against biofilms of Pseudomonas aeruginosa strain PA14. (Ph.D. thesis, University of Strathclyde, Glasgow, UK). Retrieved from http://ethos.bl.uk (EThOS ID:uk.bl.ethos668862) 11. Duman, A. D., Telci, I., Dayisoylu, K. S., Digrak, M., Demirtas, I. and Alma, M. H. (2010). Evaluation of bioactivity of linalool-rich essential oils from Ocimum basilucum and Coriandrum sativum varieties. Natural Product Communications, 5, 969-74. 12. Awen, B. Z. S., Unnithan, C. R., Ravi, S., Kermagy, A., Sasikumar, J. M., Khrbash, A. S. and Ekreem, W. L. (2011). Essential oils of Retama raetam from Libya: Chemical composition and antimicrobial activity. Natural Product Research, 25, 927-33. 13. Rattanachaikunsopon, P. and Phumkhachorn, P. (2010). Potential of coriander (Coriandrum sativum) oil as a natural antimicrobial compound in controlling Campylobacter jejuni in raw meat. Bioscience, Biotechnology and Biochemistry, 74, 31-5. 14. Lixandru, B. E., Dracea, N. O., Dragomirescu, C. C., Dragulescu, E. C., Coldea, I. L., Anton, L., Dobre, E., Rovinaru, C. and Codita, I. (2010). Antimicrobial activity of plant essential oils against bacterial and fungal species involved in food poisoning and/or food decay. Roumanian Archives of Microbiology and Immunology, 69, 224-30. 15. Gellatly, S. L. and Hancock, R. E. W. (2013). Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathogens and Disease, 67, 159-73. 16. Witkowska, A. M., Hickey, D. K., Alonso-Gomez, M. and Wilkinson, M. G. (2011). The microbiological quality of commercial herb and spice preparations used in the formulation of a chicken supreme ready meal and microbial survival following a simulated industrial heating process. Food Control, 22, 616-25. 17. Silva, F., Ferreira, S., Queiroz, J. A. and Domingues, F. C. (2011). Coriander (Coriandrum sativum L.) essential oil: its antibacterial activity and mode of action evaluated by flow cytometry. Journal of Medicinal Microbiology, 60, 1479-86. 18. Furletti, V. F., Teixeira, I. P., Obando-Pereda, G., Mardegan, R. C., Sartoratto, A., Figueira, G. M., Duarte, R. M. T., Rehder, V. L. G., Duarte, M. C. T., #246 and Fling, J. F. (2011). Action of Coriandrum sativum L. essential oil upon oral Candida albicans biofilm formation. Evidence-Based Complementary and Alternative Medicine, 2011.